MORGAN STANLEY

Holdings History for Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN)

Symbol: DAWN on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$14,448,557	1,550,274	+246,245	+19%	$9.32	Q4 2025
30 Sep 2025	0%	-0%	$9,193,406	1,304,029	-49,118	-3.6%	$7.05	Q3 2025
30 Jun 2025		0%	$11	1	0		$11.00 ^*	Q2 2025
30 Jun 2025	0%	+0%	$8,795,458	1,353,147	+643,732	+91%	$6.50	Q2 2025
31 Mar 2025	0%	-0%	$5,625,664	709,415	-370,853		$7.93	Q1 2025
31 Dec 2024	0%	+0%	$13,687,000	1,080,268	+305,757		$12.67	Q4 2024
30 Sep 2024	0%	+0%	$10,788,937	774,511	+607,265	+300%	$13.93	Q3 2024
30 Jun 2024	0%	-0%	$2,304,649	167,246	-65,304		$13.78	Q2 2024
31 Mar 2024	0%	-0%	$3,841,726	232,550	-101,889	-30%	$16.52	Q1 2024
31 Dec 2023	0%	+0%	$4,882,810	334,439	+175,993	+111%	$14.60	Q4 2023
30 Sep 2023	0%	-0%	$1,944,131	158,446	-79,258	-33%	$12.27	Q3 2023
30 Jun 2023	0%	+0%	$2,838,185	237,704	+53,785	+29%	$11.94	Q2 2023
31 Mar 2023	0%	+0%	$2,458,996	183,919	+96,654	+111%	$13.37	Q1 2023
31 Dec 2022	0%	-0%	$1,877,942	87,265	-20,100	-19%	$21.52	Q4 2022
30 Sep 2022		0%	$1,000	37	0		$27.03 ^*	Q3 2022
30 Sep 2022	0%	+0%	$2,150,000	107,365	+70,439	+191%	$20.03	Q3 2022
30 Jun 2022		0%	$2,000	114	0		$17.54 ^*	Q2 2022
30 Jun 2022	0%	+0%	$660,000	36,926	+20,510	+125%	$17.87	Q2 2022
31 Mar 2022	0%	+0%	$162,000	16,416	+2,556	+18%	$9.87	Q1 2022
31 Dec 2021	0%	+0%	$234,000	13,860	+10,899	+368%	$16.88	Q4 2021
31 Dec 2021		0%	$2,000	98	0		$20.41 ^*	Q4 2021
30 Sep 2021	0%	+0%	$70,000	2,961	+587	+25%	$23.64	Q3 2021
30 Jun 2021	0%	+0%	$54,000	2,374	+2,374	NEW	$22.75	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.